REPRESENTATIVE EXPERIENCE
Christopher L. Nasson
Healthcare Fraud
Represented a Fortune 500 global healthcare and pharmaceutical company in SEC investigation
relating to accounting practices. The SEC declined to bring an enforcement action.
Represented a global, public company in connection with a Department of Justice investigation
involving alleged Food, Drug, and Cosmetic Act violations.
Represented a public healthcare company in connection with a Department of Justice investigation
involving alleged price gouging and anti-competitive conduct.
Represented an academic medical center in connection with a Department of Justice foreign
influence investigation.
Represented a healthcare company in connection with a federal investigation involving alleged
Anti-Kickback Statute violations. The case was resolved with a declination of prosecution.
Represented a healthcare provider and research clinic in a state Attorney General’s Office
investigation involving alleged Stark Law violations and improper Medicare and Medicaid
billings. The case was resolved with a declination of prosecution.
Represented a healthcare system in a federal investigation involving alleged Stark Law,
Anti-Kickback Statute, and False Claims Act violations.
Securities, Financial, and Tax Fraud
Represented a senior executive in the FTX implosion and related criminal case, US v. Samuel
Bankman-Fried. No charges were brought against the client in any jurisdiction.
Represented a Registered Investment Advisor in a securities fraud investigation brought by the
Department of Justice and Securities and Exchange Commission. Neither agency brought charges.
Represented a crypto and FinTech company in connection with a fraud and money laundering
investigation.
Represented a public pharmaceutical and biotech company in a SEC securities fraud investigation.
The SEC declined to charge.
Represented a financial services company in a civil investigation brought by a state Attorney
General’s Office.
Represented a global asset management firm in a federal antitrust and financial fraud
investigation.
Represented a corporate director in connection with a federal tax and corporate fraud
investigation.
Represented a private equity firm in securities litigation relating to false representations in
violation of the Securities Exchange Act.
Represented a senior executive in the SDNY's Galleon Group/New Castle Partners insider trading
investigation. The DOJ declined to bring charges.
Represented individuals in connection with a federal tax evasion matter.
False Claims Act
Represented a financial services company in a False Claims Act investigation. The Department of
Justice declined intervention.
Represented a public healthcare company and its subsidiaries in connection with a False Claims
Act investigation brought by the Department of Justice’s Civil Division.
Represented an insurance company in a False Claims Act investigation.
Represented a tech company in a False Claims Act investigation.
Represented a pharmacy roll-up company in a False Claims Act investigation led by the US
Attorney’s Office for the Eastern District of New York. The government closed the investigation
with no civil or criminal charges.
Foreign Corrupt Practices Act
Represented a public global energy company in parallel DOJ and SEC Foreign Corrupt Practices Act
investigations involving conduct occurring in the US, Russia, Kazakhstan, China, and the
Netherlands. Neither agency brought charges.
Represented a senior executive in a Foreign Corrupt Practices Act investigation brought by the
DOJ's FCPA Section.
Internal and Cross-Border Investigations
Represented a public global energy company and its senior executives in a cross-border,
multi-jurisdictional criminal investigation and civil arbitration.
Led an internal investigation of a Fortune 500 bank holding company in response to employee
allegations involving workplace discrimination.
Represented an aerospace engineering company in a federal investigation involving alleged Export
Administration Regulations and International Traffic in Arms Regulations violations.
Led an internal investigation of a healthcare company in response to whistleblower allegations
of healthcare, wire, and securities fraud.
Led an internal investigation of a public biotechnology company in response to whistleblower
allegations of accounting violations and misbranding drugs and medical devices.
Public Corruption
Represented an executive in the federal grand jury and congressional investigations in United
States v. Hunter Biden. No charges were brought against the client in any jurisdiction.
Represented an asset management firm in a federal public corruption investigation.
Represented a public global energy company in a public corruption and commercial bribery
investigation brought by the Manhattan District Attorney’s Office. No charges were brought.
Regulatory Compliance and Counseling
Designed anti-corruption and trade compliance policies and training for a global technology
company.
Advised public media company on Office of Foreign Assets Control compliance.
Pro Bono
Represented a pro bono client wrongfully convicted of first-degree murder and sentenced to life
imprisonment. After prevailing before the trial court and state supreme court, persuaded the
District Attorney’s Office to dismiss all charges, resulting in the client’s release from prison
after serving more than 36 years for a crime he did not commit.
